Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

ReoPro and peripheral arterial intervention to improve clinical outcome in patients with peripheral arterial disease – a randomized prospective trial (RIO-Trial)

Trial Profile

ReoPro and peripheral arterial intervention to improve clinical outcome in patients with peripheral arterial disease – a randomized prospective trial (RIO-Trial)

Active, no longer recruiting
Phase of Trial: Phase II/III

Latest Information Update: 17 Jan 2017

At a glance

  • Drugs Abciximab (Primary)
  • Indications Death; Embolism and thrombosis; Peripheral arterial occlusive disorders
  • Focus Therapeutic Use
  • Acronyms RIO
  • Most Recent Events

    • 02 Oct 2006 Status change
    • 31 Dec 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top